Clinic
Nor-Lea Hospital District
Nor-Lea Hospital District was paid $18.25M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 43% of everything it billed.
33Billing provider infoNOR-LEA HOSPITAL DISTRICT
LOVINGTON, NM 88260
LOVINGTON, NM 88260
33aNPI1457393829assigned 06/12/2006
33bProvider typeClinic/Center
28Total paid$18.25M
24GClaims187,937
24DCodes billed85
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in New Mexico
Rank by total paid#2 of 52
Median peer was paid$827K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,057 | $2.56M | |
| 2019 | 29,643 | $2.62M | |
| 2020 | 23,605 | $1.96M | |
| 2021 | 26,067 | $2.85M | |
| 2022 | 32,239 | $3.17M | |
| 2023 | 25,723 | $2.67M | |
| 2024incomplete | 21,603 | $2.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 43% | 52,440 | 46,975 | $7.79M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 31,017 | 28,602 | $4.76M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.8% | 8,626 | 8,250 | $1.24M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.4% | 3,464 | 3,458 | $613K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.8% | 11,503 | 8,313 | $518K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.6% | 2,941 | 2,917 | $482K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 10,532 | 10,210 | $354K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.7% | 1,699 | 1,696 | $311K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.7% | 2,099 | 1,655 | $308K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 6,599 | 5,982 | $217K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 900 | 896 | $164K |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 6,539 | 6,469 | $131K |
73 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 958 | $131K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 751 | $128K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 795 | $114K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,344 | $79K |
| 90461 | <1% | 3,450 | $73K | |
| 81002 | <1% | 2,103 | $72K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 438 | $70K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 5,815 | $67K |
| 87254 | <1% | 4,647 | $66K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,410 | $63K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 419 | $62K |
| 87430 | <1% | 4,830 | $61K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 453 | $56K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,852 | $43K |
| 99490 | Ccm add 20min | <1% | 2,063 | $43K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,432 | $26K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 281 | $25K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 643 | $23K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 125 | $23K |
| 81025 | <1% | 772 | $22K | |
| 92552 | <1% | 895 | $16K | |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 175 | $14K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,869 | $13K |
| 99201 | <1% | 92 | $11K | |
| 99173 | <1% | 1,013 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 399 | $7K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 76 | $7K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 864 | $6K |
| 81003 | <1% | 539 | $6K | |
| 87807 | <1% | 169 | $5K | |
| 82962 | <1% | 762 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 27 | $4K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 12 | $3K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 15 | $3K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 18 | $2K |
| 99205 | Prolong outpt/office vis | <1% | 13 | $2K |
| 99381 | <1% | 13 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 41 | $1K |
| 90732 | <1% | 12 | $974.22 | |
| 90756 | <1% | 321 | $777.71 | |
| 90658 | <1% | 38 | $646.38 | |
| 90715 | <1% | 56 | $522.70 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 40 | $462.15 |
| 0002A | <1% | 269 | $449.27 | |
| 90670 | <1% | 920 | $414.20 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 12 | $393.11 |
| 0071A | <1% | 13 | $282.19 | |
| 0001A | <1% | 242 | $256.94 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 15 | $228.96 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 101 | $215.03 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 25 | $144.32 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 160 | $137.30 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 39 | $105.16 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 31 | $51.83 |
| 90674 | <1% | 15 | $46.63 | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | <1% | 14 | $20.53 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 13 | $8.33 |
| 90633 | <1% | 340 | $5.35 | |
| 90648 | <1% | 681 | $2.28 | |
| 90681 | <1% | 415 | $2.09 | |
| 90723 | <1% | 464 | $1.99 | |
| 90698 | <1% | 37 | $0.17 | |
| 90655 | <1% | 67 | $0.13 | |
| 90707 | <1% | 39 | $0.11 | |
| 90686 | <1% | 143 | $0.08 | |
| 90716 | <1% | 28 | $0.08 | |
| 90734 | <1% | 103 | $0.06 | |
| 90656 | <1% | 149 | $0.05 | |
| 90651 | <1% | 53 | $0.01 | |
| 90688 | 0% | 28 | $0.00 | |
| 0004A | 0% | 26 | $0.00 | |
| 90700 | 0% | 40 | $0.00 | |
| 90685 | 0% | 56 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHAW, DAVID (CEO/ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Nor-Lea Hospital District | Lovington, NM | $53.24M |
| Nor-Lea Hospital District | Hobbs, NM | $6.83M |
| Nor-Lea Hospital District | Hobbs, NM | $2.02M |
| Nor-Lea Hospital District | Tatum, NM | $254K |
| Nor-Lea Hospital District | Lovington, NM | $251K |
| Nor-Lea Hospital District | Lovington, NM | $98K |
| Nor-Lea Hospital District | Hobbs, NM | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.